Centiva Capital, LP Roivant Sciences Ltd. Call Options Transaction History

Centiva Capital, LP

  • $9.73 Billion
  • Q3 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$10.74 - $15.28 $871,014 - $1.24 Million
81,100 Added 21.35%
461,000 $6.97 Million
Q2 2025

Aug 13, 2025
BUY
$9.08 - $11.62 $3.45 Million - $4.41 Million
379,900 New
379,900 $4.28 Million
Q4 2023

Feb 14, 2024
BUY
$8.38 - $11.58 $1.68 Million - $2.32 Million
200,000 New
200,000 $2.25 Million

Others Institutions Holding ROIV

# of Institutions
374
Shares Held
436M
Call Options Held
6.03M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $14.3B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email